Fedratinib FDR Impurity 3
Fedratinib FDR Impurity 3 or 3-((5-methyl-2-((4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)amino)pyrimidine-4-yl)amino)benzenesulfonamide dihydrochloride is an associate impurity of Fedratinib. This medication is employed to treat a definite variety of cancer (myelofibrosis). Fedratinib belongs to a category of medicine referred to as enzyme inhibitors. It works by fastness or stopping the expansion of cancer cells.
“Sci-Hub, Fedratinib: First Approval. Drugs, 10.1007/S40265-019-01205-x.” Sci-Hub.se, 2019, sci-hub.se/link.springer.com/article/10.1007/s40265-019-01205-x.